November 27-28 2024

Lyon, France

COMMITTEES

SCIENTIFIC COMMITTEE

Sandra Morel

Director, Research Project Leader, Discovery Performance Unit

GSK Vaccines

Bruno Lina

University Professor and Hospital Practitioner, Director

National Reference Center for respiratory infections virus, VirPath Laboratory, University Lyon 1

Cyril Guyard

Deputy CSO

Bioaster

Sébastien Coyne

Senior Project Leader, Discovery Research

Aurobac Therapeutics

Laure Delhon

Events Manager and Communication

MabDesign

Natalia Bomchil

Innovation Director

Lyonbiopôle

Daniel Larocque

Microbiology-Immunology Platform Manager

Sanofi

Michel Perez

Head of Development Of Innovation Department

Pasteur Institute

Jean François Llitjos

Scientific and medical Expert Open innovation and Partnership

bioMérieux

Fabienne Venet

University professor, Hospital practitioner

Hospices Civils de Lyon

Robbert van der Most

Vice President Translational Science

BioNTech

Sherif Abouelhadid

Head at Biological and Pharmacological Pillar at Antimicrobial Resistance Centre

London school of Hygiene & Tropical Medicine

Nadia Khelef

Coordinator

National Acceleration Strategy Emerging Infectious Diseases and CBRN Threats, France

General investment secretary office

Health Innovation Agency, France

Francesca Bernardini

VP In vitro Biology

Evotec

ORGANISATION COMMITTEE

Ana Antunes

Head of Scientific Events and Communication

MabDesign

Sally Peschiera

Events Manager

Lyonbiopôle

Laure Delhon

Events Manager and Communication

MabDesign

Natalia Bomchil

Innovation Director

Lyonbiopôle

Stéphanie Pelège

Responsible Comunication

Lyonbiopôle